An innovative service company focusing on the field of drug quality control
  • News

  • Company News
  • Industry information
  • Recruitment

  • Contact Us

  • News

    Contact Us

    You are here:Home >> News >> Company News

    Company News

    SZEB Supplies Afatinib Impurities

    Time:2022-07-15 Views:59
           Afatinib,is a medication used to treat non-small cell lung carcinoma (NSCLC). It belongs to the tyrosine kinase inhibitor family of medications.
           Afatinib is an oral, irreversible ErbB family blocker that covalently binds to the kinase domains of epidermal growth factor receptor (EGFR), human EGFRs (HER) 2, and HER4, resulting in irreversible inhibition of tyrosine kinase autophosphorylation. 
           To support your analysis and help ensure the accuracy of quality processes, we supply a range of Afatinib-related impurities standards with certified COA and characterization data like Mass, HPLC, NMR & TGA report.
           The following are some of the impurities of Afatinib: